Selecta Biosciences ImmTOR - Immune Tolerance Platform
Selecta Biosciences’ immune tolerance platform, ImmTOR, is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses.
What is ImmTOR?
Selecta Biosciences’ immune tolerance platform, ImmTOR, is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses.
ImmTOR has the potential to unlock the full potential of biologic therapies, including enabling redosing of life saving gene therapies, and to restore self-tolerance in autoimmune diseases.
Controlled, Scalable Manufacturing
The universal formulation of ImmTORTM is produced at a commercial scale via a well-controlled and scalable manufacturing process.
Selecta has developed a commercial-scale, Good Manufacturing Practice (GMP), process to ensure that ImmTOR is consistently produced and controlled according to quality standards.
ImmTOR’s tolerogenic activity has been reproduced in multiple independent laboratories using a range of biologic therapies and immunogenic antigens, validating the platform’s ability to mitigate anti-drug antibodies. This research has been published in several high-level peer-reviewed journals including Nature Nanotechnology, Nature Communications and Proceedings of the National Academy of Sciences of the United States of America (PNAS).
Customer reviews
No reviews were found for Selecta Biosciences ImmTOR - Immune Tolerance Platform. Be the first to review!